Terug
53
Dagbereik
€ 28,18
€ 28,18
52-Weeksbereik
€ 28,18
€ 28,18
Volume
300
50D / 200D Gem.
€ 28,18
/
€ 28,18
Vorige Slotkoers
€ 28,18
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (633 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 0,2 |
| P/B | 0,0 | 2,8 |
| ROE % | 11,8 | 3,8 |
| Net Margin % | 3,8 | 3,9 |
| Rev Growth 5Y % | 6,0 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 2,05
€ 1,98 – € 2,19
|
1,01T | 1 |
| FY2029 |
€ 1,96
€ 1,89 – € 2,10
|
965,67B | 1 |
| FY2028 |
€ 1,96
€ 1,89 – € 2,09
|
951,91B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | € 0,53 | € 0,49 | -7,9% |
| 2025-08-14 | € 0,48 | € 0,47 | -1,4% |
| 2025-05-13 | € 0,39 | € 0,41 | +3,9% |
| 2025-02-12 | € 0,49 | € 0,52 | +5,5% |
| 2024-11-14 | € 0,44 | € 0,40 | -9,0% |
| 2024-08-14 | € 0,38 | € 0,39 | +2,9% |
| 2024-05-15 | € 0,35 | € 0,36 | +3,4% |
| 2024-02-14 | € 0,53 | € 0,53 | +0,6% |
Dividend History
7 yr streakYield
0,03%
Payout Ratio
0,46%
Growth (3Y)
10,74%
Growth (5Y)
6,16%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | — | € 0,33 | 2,72% |
| Sep 30, 2025 | Dec 01, 2025 | € 0,44 | 3,09% |
| Mar 31, 2025 | Jun 23, 2025 | € 0,43 | 3,15% |
| Sep 30, 2024 | Dec 10, 2024 | € 0,45 | 2,95% |
| Mar 28, 2024 | Jun 24, 2024 | € 0,38 | 3,11% |
| Sep 28, 2023 | Dec 04, 2023 | € 0,38 | 3,11% |
| Mar 30, 2023 | Jun 26, 2023 | € 0,38 | 2,96% |
| Sep 29, 2022 | Dec 05, 2022 | € 0,35 | 2,63% |
| Mar 30, 2022 | Jun 27, 2022 | € 0,30 | 2,40% |
| Sep 29, 2021 | Dec 06, 2021 | € 0,31 | 2,00% |
| Mar 30, 2021 | Jun 28, 2021 | € 0,32 | 1,74% |
| Sep 29, 2020 | Dec 14, 2020 | € 0,33 | 1,73% |
| Mar 30, 2020 | Jun 22, 2020 | € 0,31 | 1,98% |
| Sep 27, 2019 | Dec 09, 2019 | € 0,31 | 1,87% |
| Mar 27, 2019 | Jun 24, 2019 | € 0,30 | 2,07% |
| Sep 26, 2018 | Dec 10, 2018 | € 0,29 | 1,70% |
| Mar 28, 2018 | Jun 25, 2018 | € 0,31 | 1,22% |
| Sep 27, 2017 | Dec 08, 2017 | € 0,24 | 1,47% |
| Mar 29, 2017 | Jun 26, 2017 | € 0,50 | 1,34% |
| Sep 28, 2016 | Dec 09, 2016 | € 0,45 | 1,08% |
Belangrijkste Punten
Revenue grew 6,03% annually over 5 years — modest growth
ROE of 11,76% — decent returns on equity
Debt/Equity of 0,14 — conservative balance sheet
Generating 6,90B in free cash flow
P/E of 0,11 — trading at a low valuation
Capital efficient — spends only 4,27% of revenue on capex
Groei
Revenue Growth (5Y)
6,03%
Revenue (1Y)6,66%
Earnings (1Y)5,58%
FCF Growth (3Y)801,88%
Kwaliteit
Return on Equity
11,76%
ROIC10,82%
Net Margin3,84%
Op. Margin5,55%
Veiligheid
Debt / Equity
0,14
Current Ratio1,69
Interest Coverage271,32
Waardering
P/E Ratio
0,11
Forward P/E16,56
P/B Ratio0,01
EV/EBITDA-0,52
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,66% | Revenue Growth (3Y) | 7,76% |
| Earnings Growth (1Y) | 5,58% | Earnings Growth (3Y) | 9,38% |
| Revenue Growth (5Y) | 6,03% | Earnings Growth (5Y) | 4,97% |
| Profitability | |||
| Revenue (TTM) | 801,81B | Net Income (TTM) | 30,75B |
| ROE | 11,76% | ROA | 6,93% |
| Gross Margin | 25,45% | Operating Margin | 5,55% |
| Net Margin | 3,84% | Free Cash Flow (TTM) | 6,90B |
| ROIC | 10,82% | FCF Growth (3Y) | 801,88% |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 1,69 |
| Interest Coverage | 271,32 | ||
| Dividends | |||
| Dividend Yield | 0,03% | Payout Ratio | 0,46% |
| Dividend Growth (3Y) | 10,74% | Dividend Growth (5Y) | 6,16% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0,11 | Forward P/E | 16,56 |
| P/B Ratio | 0,01 | P/S Ratio | 0,00 |
| PEG Ratio | 2,89 | Forward PEG | N/A |
| EV/EBITDA | -0,52 | Fwd EV/EBITDA | -0,38 |
| Forward P/S | 0,00 | Fwd Earnings Yield | 6,04% |
| FCF Yield | 209,25% | ||
| Market Cap | 3,30B | Enterprise Value | -22,99B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 801,81B | 751,78B | 690,46B | 648,73B | 634,31B |
| Net Income | 30,75B | 29,13B | 25,70B | 23,85B | 25,33B |
| EPS (Diluted) | 262,91 | 249,07 | 219,82 | 204,01 | 216,63 |
| Gross Profit | 204,09B | 189,32B | 1,29B | 1,29B | 1,43B |
| Operating Income | 44,50B | 41,00B | 37,45B | 34,05B | 37,35B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 444,01B | 420,21B | 2,72B | 2,68B | 2,79B |
| Total Liabilities | 174,29B | 167,12B | 943,78M | 864,00M | 935,47M |
| Shareholders' Equity | 269,71B | 253,09B | 236,33B | 220,59B | 205,16B |
| Total Debt | 38,67B | 35,00B | 7,07M | 4,35M | 1,03M |
| Cash & Equivalents | 64,96B | 69,70B | 80,87B | 89,33B | 86,50B |
| Current Assets | 216,78B | 208,24B | 205,91B | 199,54B | 194,26B |
| Current Liabilities | 128,51B | 155,47B | 113,25B | 96,05B | 95,12B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#242 of 834
Recente Activiteit
Uitgestapt
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt
Defensive Investing (Benjamin Graham)
Mar 24, 2026